What is the current Singleplex Immunoassay market size?

The Singleplex Immunoassay market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Singleplex Immunoassay market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Singleplex Immunoassay market?

Key drivers include advancements in technology and rising healthcare expenditures, fueling future outlook.

What challenges does the Singleplex Immunoassay market face?

The market faces challenges such as high development costs and stringent regulatory requirements.

Which regions are the leaders in the Singleplex Immunoassay market?

North America and Europe are the regional leaders, accounting for a significant market share.

Who are the top companies in the Singleplex Immunoassay market?

Top companies include major players such as Roche and Abbott, dominating the market landscape.

What future opportunities exist in the Singleplex Immunoassay market?

Emerging markets and increasing adoption of point-of-care testing present future opportunities for growth.

How does technology impact the Singleplex Immunoassay market?

Advances in technology, such as microfluidics, improve assay sensitivity and drive market growth and innovation.

What is the current regulatory landscape for the Singleplex Immunoassay market?

The regulatory landscape is characterized by strict guidelines and standards, ensuring product safety and efficacy.

What is the future outlook for the Singleplex Immunoassay market?

The future outlook is positive, with increasing demand and advancements in technology driving market expansion.

Global Singleplex Immunoassay Market Value Is Forecast To Reach By 2034 With CAGR

Singleplex Immunoassay by Application (Hospitals & Research Institutes, Reference Laboratories, Pharmaceutical & Biotechnology Companies, Others), by Types (Protein-Based Assays, Nucleic Acid Based Assays, Cell-Based Assays, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $8.7 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Singleplex Immunoassay Market Overview

The Singleplex Immunoassay market refers to the diagnostic testing industry that utilizes singleplex immunoassay techniques to detect and quantify specific biomolecules. As a crucial segment of the in vitro diagnostics market, the Singleplex Immunoassay market size is estimated to be around $1.4 billion. The growth outlook for the Singleplex Immunoassay market forecast appears promising, with a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2026 to 2033, driven by factors such as the increasing prevalence of chronic diseases and the rising demand for diagnostic testing. The industry expansion is expected to be driven by technological advancements, regulatory approvals, and the growing need for accurate and reliable diagnostic testing. The scope of the Singleplex Immunoassay market encompasses various applications, including clinical diagnostics, research and development, and pharmaceutical testing, with key synonyms including ELISA, radioimmunoassay, and lateral flow assays.

Loading chart…

The Singleplex Immunoassay market is expected to be driven by key forces such as technological shifts towards automation and miniaturization, regulatory approvals and compliance, and changing consumer behavior towards preventive healthcare. The largest region for the Singleplex Immunoassay market is expected to be North America, while the fastest-growing region is anticipated to be the Asia-Pacific region, driven by increasing healthcare expenditure and infrastructure development. The market growth is expected to be influenced by the growing demand for point-of-care testing, increasing adoption of immunoassay techniques, and advances in technology, leading to a promising outlook for the Singleplex Immunoassay market forecast.

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	18.92 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Luminex; Thermo Fisher Scientific; Illumina; Bio-Rad; Qiagen; Abcam; BD; Merck; Agilent Technologies; Quanterix; Bio-Techne; Olink; Seegene; BioVendor
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Singleplex Immunoassay market is poised for significant growth, driven by increasing demand for accurate and reliable diagnostic testing. The growth forecast for the Singleplex Immunoassay market size is promising, with key drivers influencing the trajectory of the industry.

Growth Drivers2 items

Advances in technology, such as the development of microfluidics and nanotechnology, are enabling the creation of more sensitive and specific Singleplex Immunoassay tests, driving adoption and growth in the Singleplex Immunoassay market

The rising prevalence of chronic diseases, such as diabetes and cancer, is fueling demand for diagnostic testing, including Singleplex Immunoassay, and contributing to the expansion of the Singleplex Immunoassay market size

Restraints2 items

The high cost of developing and validating Singleplex Immunoassay tests is a significant restraint, limiting the growth forecast for the Singleplex Immunoassay market and making it challenging for new entrants to compete

Stringent regulatory requirements and the need for FDA clearance can slow the launch of new Singleplex Immunoassay products, hindering the growth of the Singleplex Immunoassay market size

Opportunities2 items

The increasing adoption of point-of-care testing is creating opportunities for Singleplex Immunoassay market players to develop innovative, user-friendly products that can be used in decentralized settings, driving growth in the Singleplex Immunoassay market

The growing demand for personalized medicine is driving the need for more targeted and specific diagnostic testing, including Singleplex Immunoassay, and presenting opportunities for market players to develop tailored solutions

Challenges2 items

The Singleplex Immunoassay market faces intense competition from multiplex testing platforms, which can detect multiple analytes simultaneously, making it challenging for Singleplex Immunoassay market players to differentiate their products and maintain market share

The need for standardization and harmonization of Singleplex Immunoassay tests and results is a significant challenge, as it requires collaboration and agreement among industry stakeholders, regulatory bodies, and healthcare professionals

Market Segmentation

Loading chart…

The Singleplex Immunoassay segmentation by application is a crucial aspect of understanding the market dynamics. This segmentation category contributes significantly to the overall Singleplex Immunoassay market size, as it highlights the various uses of Singleplex Immunoassay across different industries. The main applications of Singleplex Immunoassay include infectious disease testing, oncology testing, and cardiovascular disease testing, among others. Each of these applications has a distinct market size and growth rate, influencing the overall market taxonomy.

The types of Singleplex Immunoassay, including subtypes such as [object Object] and [object Object], play a vital role in determining the market size. Types of Singleplex Immunoassay are categorized based on the technology used, such as radioimmunoassay, enzyme-linked immunosorbent assay (ELISA), and chemiluminescence immunoassay. Each type has its own strengths and weaknesses, and the market demand for each type varies depending on the application and industry. Understanding the types of Singleplex Immunoassay is essential for market players to develop targeted strategies and products.

Singleplex Immunoassay Segmentation Breakdown10 items

Application

Hospitals & Research Institutes

Reference Laboratories

Pharmaceutical & Biotechnology Companies

Others

Types

Protein-Based Assays

Nucleic Acid Based Assays

Cell-Based Assays

Others

Regional Insights

Loading chart…

The Singleplex Immunoassay market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market, driven by factors such as high adoption rates of advanced diagnostic technologies, favorable policies and investments in healthcare infrastructure, and a mature ecosystem.

The fastest-growing region is expected to be Asia Pacific, driven by increasing demographics and infrastructure development, rising adoption of point-of-care diagnostics, and government investments in healthcare. Europe is also expected to contribute significantly to the Singleplex Immunoassay market growth, with key drivers including a large patient population, policies supporting healthcare innovation, and a strong ecosystem for research and development.

Latin America and Middle East & Africa are also expected to experience growth, albeit at a slower pace, driven by factors such as increasing adoption of diagnostic technologies, improving infrastructure, and rising investments in healthcare. The regional forecast indicates that these regions will contribute around 10% and 5% to the global market, respectively.

Competitive Landscape

The Singleplex Immunoassay market is moderately consolidated, driven by a mix of global players and local companies. The Singleplex Immunoassay competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and distribution networks, while local companies concentrate on pricing and regional partnerships.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. Key players in the market include:

Luminex: regional expansion

Thermo Fisher Scientific: innovation pipeline

Illumina: premium pricing

Bio-Rad: OEM tie-ups

Qiagen: local manufacturing

Abcam: vertical integration

Key Singleplex Immunoassay Companies14 items

Luminex

Thermo Fisher Scientific

Illumina

Bio-Rad

Qiagen

Abcam

Merck

Agilent Technologies

Quanterix

Bio-Techne

Olink

Seegene

BioVendor

Market Ecosystem

The Singleplex Immunoassay ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of Singleplex Immunoassay products and services. The ecosystem's boundaries are defined by the flow of goods, services, and information from raw material suppliers to end users, with each segment influencing the overall efficiency and effectiveness of the ecosystem.

Raw material suppliers — providing critical components

Technology providers — developing assay technologies

OEMs / manufacturers — producing Singleplex Immunoassay systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support

End users / buyers — utilizing Singleplex Immunoassay products

Regulators/standards bodies — establishing guidelines and approvals

Within the Singleplex Immunoassay ecosystem, control points are primarily held by regulators and end users, as they influence adoption and drive demand. Dependency risks arise from input constraints, standards, and approvals, which can impact the supply chain and overall ecosystem efficiency. Switching costs and partnerships between participants can also affect the ecosystem's dynamics. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market needs, highlighting the importance of a thorough value chain analysis to understand the complex interactions within the Singleplex Immunoassay ecosystem.

Recent Industry Insights

The Singleplex Immunoassay industry has witnessed significant developments over the last 12-18 months, shaping the Singleplex Immunoassay industry trends. Recent partnerships between key players have led to the expansion of product portfolios and enhancement of technological capabilities. Notable mergers and acquisitions have also resulted in increased consolidation, driving growth and innovation in the market. Furthermore, several product and technology launches have improved assay sensitivity and specificity, addressing the evolving needs of researchers and clinicians.

Additionally, regulatory changes have emphasized the importance of standardization and quality control in immunoassay development and manufacturing. A shift in consumer and enterprise trends towards personalized medicine and precision diagnostics has also fueled demand for Singleplex Immunoassay solutions. Recent funding rounds and expansions have enabled companies to invest in research and development, exploring new applications and indications for Singleplex Immunoassay technologies, ultimately driving the industry forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Singleplex Immunoassay market outlook. The market attractiveness is moderate, driven by increasing demand for accurate and reliable diagnostic tests. Competitive intensity is high, with key players investing heavily in research and development to improve assay sensitivity and specificity.

The long-term outlook for the Singleplex Immunoassay market is positive, with opportunities for growth in emerging markets and innovation in point-of-care testing. However, the demand–supply balance may be affected by regulatory changes and supply chain disruptions. Key risk factors include technological advancements and changing customer needs. Overall, the Singleplex Immunoassay market outlook is promising, with opportunities for players to capitalize on growing demand and advancing technology.

11 items

1. Executive Summary

2. Singleplex Immunoassay Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Singleplex Immunoassay Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Singleplex Immunoassay Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals & Research Institutes

6.1.2. Reference Laboratories

6.1.3. Pharmaceutical & Biotechnology Companies

6.1.4. Others

6.2. Global Singleplex Immunoassay Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Protein-Based Assays

6.2.2. Nucleic Acid Based Assays

6.2.3. Cell-Based Assays

6.2.4. Others

6.3. Global Singleplex Immunoassay Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Singleplex Immunoassay Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Singleplex Immunoassay Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Singleplex Immunoassay Market Competition by Key Manufacturers

8.1. Global Singleplex Immunoassay Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Singleplex Immunoassay: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Luminex

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Illumina

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Qiagen

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abcam

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. BD

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Merck

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Agilent Technologies

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Quanterix

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Bio-Techne

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Olink

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Seegene

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. BioVendor

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Singleplex Immunoassay Market

Figure 4: Global Singleplex Immunoassay Market: Drivers

Figure 5: Global Singleplex Immunoassay Market: Challenges

Figure 6: Global Singleplex Immunoassay Market: Trends

Figure 7: Global Singleplex Immunoassay Market: Opportunity

Figure 8: Global Singleplex Immunoassay Market: Restraint

Figure 9: Global Singleplex Immunoassay Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Singleplex Immunoassay Market Value (USD Million) By Region

Figure 15: Global Singleplex Immunoassay Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Singleplex Immunoassay Market Value (USD Million) By Region

Figure 23: Global Singleplex Immunoassay Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Singleplex Immunoassay Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Singleplex Immunoassay Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Singleplex Immunoassay Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Singleplex Immunoassay Market Value (USD Million) By Region

Table 10: Global Singleplex Immunoassay Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Singleplex Immunoassay Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Singleplex Immunoassay Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Singleplex Immunoassay Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Luminex Basic Information And Sales Area

Table 31: Luminex. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Illumina Basic Information And Sales Area

Table 35: Illumina. Products Portfolio

Table 36: Bio-Rad Basic Information And Sales Area

Table 37: Bio-Rad. Products Portfolio

Table 38: Qiagen Basic Information And Sales Area

Table 39: Qiagen. Products Portfolio

Table 40: Abcam Basic Information And Sales Area

Table 41: Abcam. Products Portfolio

Table 42: BD Basic Information And Sales Area

Table 43: BD. Products Portfolio

Table 44: Merck Basic Information And Sales Area

Table 45: Merck. Products Portfolio

Table 46: Agilent Technologies Basic Information And Sales Area

Table 47: Agilent Technologies. Products Portfolio

Table 48: Quanterix Basic Information And Sales Area

Table 49: Quanterix. Products Portfolio

Table 50: Bio-Techne Basic Information And Sales Area

Table 51: Bio-Techne. Products Portfolio

Table 52: Olink Basic Information And Sales Area

Table 53: Olink. Products Portfolio

Table 54: Seegene Basic Information And Sales Area

Table 55: Seegene. Products Portfolio

Table 56: BioVendor Basic Information And Sales Area

Table 57: BioVendor. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Singleplex Immunoassay Market Value (USD Million) By Region

Table 63: Global Singleplex Immunoassay Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Singleplex Immunoassay Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.70 million
Revenue forecast in 2033	18.92 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Luminex; Thermo Fisher Scientific; Illumina; Bio-Rad; Qiagen; Abcam; BD; Merck; Agilent Technologies; Quanterix; Bio-Techne; Olink; Seegene; BioVendor
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and the need for FDA clearance can slow the launch of new Singleplex Immunoassay products, hindering the growth of the Singleplex Immunoassay market size

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Singleplex Immunoassay Segmentation Breakdown10 items

Application

Hospitals & Research Institutes

Reference Laboratories

Pharmaceutical & Biotechnology Companies

Others

Types

Protein-Based Assays

Nucleic Acid Based Assays

Cell-Based Assays

Others

Regional Insights

Loading chart…

Competitive Landscape

Luminex: regional expansion

Thermo Fisher Scientific: innovation pipeline

Illumina: premium pricing

Bio-Rad: OEM tie-ups

Qiagen: local manufacturing

Abcam: vertical integration

Key Singleplex Immunoassay Companies14 items

Luminex

Thermo Fisher Scientific

Illumina

Bio-Rad

Qiagen

Abcam

Merck

Agilent Technologies

Quanterix

Bio-Techne

Olink

Seegene

BioVendor

Market Ecosystem

Raw material suppliers — providing critical components

Technology providers — developing assay technologies

OEMs / manufacturers — producing Singleplex Immunoassay systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support

End users / buyers — utilizing Singleplex Immunoassay products

Regulators/standards bodies — establishing guidelines and approvals

Recent Industry Insights

Analyst Overview

Table of Contents